Lv5
1125 积分 2021-02-25 加入
HR+/HER-2－早期乳腺癌复发风险与临床管理专家共识（2025版）
3天前
已关闭
Pyrotinib for HER2-amplified non-small cell lung cancer patient after progression to Afatinib: a case report
6天前
已完结
Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
6天前
已完结
Time-varying pattern of recurrence risk for Chinese breast cancer patients
9天前
已完结
Current Management of Allergic Rhinitis
4个月前
已完结
Lymphoma in patients with asthma treated with dupilumab: much ado about nothing?
5个月前
已关闭
Spectrum and treatment of anaerobic infections
8个月前
已完结
非小细胞肺癌患者贝伐珠单抗相关不良反应临床分析
8个月前
已完结
皖公网安备34019202002308
